Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women
Open Access
- 1 August 1997
- Vol. 80 (3), 435-441
- https://doi.org/10.1002/(sici)1097-0142(19970801)80:3<435::aid-cncr11>3.0.co;2-y
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer familiesNature Medicine, 1996
- The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%Nature Genetics, 1996
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996
- Germline BRCA1 185delAG mutations in Jewish women with breast cancerThe Lancet, 1996
- Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancerNature Genetics, 1996
- The complete BRCA2 gene and mutations in chromosome 13q-linked kindredsNature Genetics, 1996
- Germ-LineBRCA1Mutations in Jewish and Non-Jewish Women with Early-Onset Breast CancerNew England Journal of Medicine, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individualsNature Genetics, 1995
- Frontometaphyseal dysplasia: Neonatal radiographic diagnosisAmerican Journal of Medical Genetics, 1995